Atefeh Amiri, Mohammad Hossein Pourhanifeh, Hamid Reza Mirzaei, Javid Sadri Nahand, Mohsen Moghoofei, Roxana Sahebnasagh, Hamed Mirzaei* and Michael R. Hamblin* Pages 1 - 20 ( 20 )
Lung cancer is a malignancy with a high morbidity and mortality rate, and affected patients have low survival and poor prognosis. The therapeutic approaches for the treatment of this cancer, including radiotherapy and chemotherapy, are not particularly effective partly due late diagnosis. Therefore, the search for new diagnostic and prognostic tools is a critical issue. Novel biomarkers, such as exosomes, could be considered as potential diagnostic tools for malignancies, particularly lung cancer. Exosomes are nanovesicles, which are associated with different physiological and pathological conditions. It has been shown that these particles are released from many cells such as cancer cells, immune cells and to some degree normal cells. Exosomes could alter the behavior of target cells though intercellular transfer of their cargo (e.g., DNA, mRNA, long non-coding RNAs, microRNAs and proteins). Thus, these vehicles may play pivotal roles in various physiological and pathological conditions. The current insights into lung cancer pathogenesis suggest that exosomes are key players in the pathogenesis of this cancer. Hence, these nanovesicles and their cargos could be used as new diagnostic, prognostic and therapeutic biomarkers in the treatment of lung cancer. Besides the diagnostic roles of exosomes, their use as drug delivery systems and as cancer vaccines is under investigation. The present review summarizes the current information on the diagnostic and pathogenic functions of exosomes in lung cancer.
Exosomes, Lung cancer, Diagnostic biomarkers, MicroRNAs, Drug delivery vehicles, Cancer vaccines
Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashahd, Halal Research Center of IRI, FDA, Tehran, Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Department of Microbiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 40 Blossom Street, Boston, MA, 02114